Europe - Euronext Paris - EPA:KORI - FR0010386334 - Common Stock
The current stock price of KORI.PA is 7.36 EUR. In the past month the price decreased by -4.1%. In the past year, price decreased by -50.54%.
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| EMEIS.PA | EMEIS SA | N/A | 2.16B | ||
| GDS.PA | RAMSAY GENERALE DE SANTE SA | N/A | 991.30M | ||
| RHK.DE | RHOEN-KLINIKUM AG | 21.79 | 816.91M | ||
| GHC.MI | GAROFALO HEALTH CARE SPA | 14.69 | 477.16M | ||
| M12.DE | M1 KLINIKEN AG | 16.91 | 312.28M | ||
| LNA.PA | LNA SANTE | 11.03 | 251.69M | ||
| MED.DE | MEDICLIN AG | 4.59 | 161.50M | ||
| LIK.DE | LIMES SCHLOSSKLINIKEN AG | 22.21 | 100.92M | ||
| EIF.DE | MEDNATION AG | 16.11 | 9.55M |
Korian SE engages in the provision of services for the elderly people. The company is headquartered in Paris, Ile-De-France. The company went IPO on 2006-11-23. The firm's holdings include residential centers for the elderly, offering permanent social care and medical support; follow-up care and rehabilitation centers, including general and specialized centers. Furthermore, the Company offers hospitalization at home, which avoids or shortens the hospitalization process; and home nursing services, which allows the care prescribes by a doctor at home. Korian-Medicas' establishments are located in France, Italy, Belgium and Germany via its subsidiaries, Segesta S.p.A., Phonix GmBH, Reacti Malt SAS, Sas La Normandie, Sa La Bastide de la tourne, Sas Mapadex La Roseraie, among others.
KORIAN
21 - 25 rue Balzac
Paris ILE-DE-FRANCE FR
Employees: 55912
Phone: 33155375200.0
Korian SE engages in the provision of services for the elderly people. The company is headquartered in Paris, Ile-De-France. The company went IPO on 2006-11-23. The firm's holdings include residential centers for the elderly, offering permanent social care and medical support; follow-up care and rehabilitation centers, including general and specialized centers. Furthermore, the Company offers hospitalization at home, which avoids or shortens the hospitalization process; and home nursing services, which allows the care prescribes by a doctor at home. Korian-Medicas' establishments are located in France, Italy, Belgium and Germany via its subsidiaries, Segesta S.p.A., Phonix GmBH, Reacti Malt SAS, Sas La Normandie, Sa La Bastide de la tourne, Sas Mapadex La Roseraie, among others.
The current stock price of KORI.PA is 7.36 EUR. The price decreased by -3.79% in the last trading session.
KORIAN (KORI.PA) has a dividend yield of 3.27%. The yearly dividend amount is currently 0.55.
KORI.PA has a ChartMill Technical rating of 1 out of 10 and a ChartMill Fundamental rating of 2 out of 10.
The Revenue of KORIAN (KORI.PA) is expected to grow by 8.42% in the next year. Check the estimates tab for more information on the EPS, Sales, EBIT and EBITDA future analyst estimates.
ChartMill assigns a technical rating of 1 / 10 to KORI.PA. When comparing the yearly performance of all stocks, KORI.PA is a bad performer in the overall market: 91.42% of all stocks are doing better.
ChartMill assigns a fundamental rating of 2 / 10 to KORI.PA. Both the profitability and financial health of KORI.PA have multiple concerns.
Over the last trailing twelve months KORI.PA reported a non-GAAP Earnings per Share(EPS) of 0.19. The EPS decreased by -77.1% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 0.5% | ||
| ROA | 0.15% | ||
| ROE | 0.62% | ||
| Debt/Equity | 1.96 |
14 analysts have analysed KORI.PA and the average price target is 12.22 EUR. This implies a price increase of 66.04% is expected in the next year compared to the current price of 7.36.
For the next year, analysts expect an EPS growth of -69.88% and a revenue growth 8.42% for KORI.PA